Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • 2025-05
  • 2025-04
  • Cy5 TSA Fluorescence System Kit: High-Sensitivity Signal ...

    2025-11-05

    Cy5 TSA Fluorescence System Kit: High-Sensitivity Signal Amplification

    Executive Summary: The Cy5 TSA Fluorescence System Kit (SKU: K1052) is a tyramide signal amplification kit designed for sensitive detection in immunohistochemistry, immunocytochemistry, and in situ hybridization. This kit employs horseradish peroxidase (HRP)-mediated deposition of Cyanine 5-labeled tyramide, achieving up to 100-fold signal amplification compared to standard fluorescence assays (Hong et al., 2023). The amplification process is completed in under ten minutes, with fluorescent detection at 648 nm excitation and 667 nm emission. The system is validated for detection of low-abundance protein and nucleic acid targets while reducing primary antibody consumption. Storage guidelines ensure reagent stability for up to two years under specified conditions (APExBIO product page).

    Biological Rationale

    Modern biological research often requires detection of proteins or nucleic acids expressed at low abundance. Traditional immunohistochemistry (IHC), immunocytochemistry (ICC), and in situ hybridization (ISH) techniques suffer from limited sensitivity when target molecules are scarce (Hong et al., 2023). This limitation can obscure detection of key regulatory proteins, such as SCD1 and CD36, especially in studies of cancer metabolism. Tyramide signal amplification (TSA), especially when combined with bright, stable fluorophores like Cyanine 5 (Cy5), overcomes these barriers by amplifying signal while preserving spatial resolution. This is crucial for spatial transcriptomics and single-cell analyses, where detection sensitivity and specificity are paramount (GalanthamineHBr review). The Cy5 TSA Fluorescence System Kit addresses this need by integrating HRP-catalyzed tyramide deposition with Cy5 labeling, enabling visualization of low-abundance targets in complex tissue environments.

    Mechanism of Action of Cy5 TSA Fluorescence System Kit

    The Cy5 TSA Fluorescence System Kit leverages the enzymatic activity of horseradish peroxidase (HRP) conjugated to secondary antibodies. Upon addition of the Cy5-labeled tyramide substrate, HRP catalyzes the conversion of tyramide into highly reactive radicals in the presence of hydrogen peroxide. These radicals covalently bind to tyrosine residues proximal to the HRP enzyme, resulting in dense deposition of Cy5 fluorophores at the site of the target antigen or nucleic acid probe (Cy5 TSA Fluorescence System Kit). This process typically completes within 10 minutes at room temperature (20–25°C). The resulting fluorescent signal is both stable and highly localized, allowing for direct visualization using standard or confocal fluorescence microscopes at an excitation/emission of 648/667 nm.

    • HRP-conjugated antibody binding: Secondary antibody labeled with HRP binds to the primary antibody or probe.
    • Tyramide substrate activation: Cy5-labeled tyramide is oxidized by HRP in the presence of hydrogen peroxide.
    • Covalent deposition: Activated tyramide radicals rapidly and covalently couple to nearby tyrosine residues.
    • Signal readout: The resulting high-density Cy5 fluorophore labeling enables sensitive detection of the target.

    This localized amplification minimizes background and preserves tissue morphology.

    Evidence & Benchmarks

    • The Cy5 TSA Fluorescence System Kit achieves up to 100-fold signal amplification compared to conventional immunofluorescence protocols (Hong et al., 2023).
    • Signal amplification workflow completes in less than 10 minutes at room temperature (20–25°C) (APExBIO).
    • The kit enables detection of low-abundance proteins, including SCD1 and CD36, in tissue sections—key for studies of cancer lipid metabolism (Hong et al., 2023).
    • The fluorescence signal remains stable and photostable under standard imaging conditions, minimizing quenching artifacts (GalanthamineHBr review).
    • Reagent consumption, particularly of primary antibodies or probes, is reduced by up to 10-fold due to enhanced sensitivity (D-Lin-MC3-DMA review).
    • Reagents are stable for up to two years when stored as specified: Cy5 tyramide at -20°C, diluent/blocking reagent at 4°C (Product page).

    Applications, Limits & Misconceptions

    The Cy5 TSA Fluorescence System Kit is validated for multiple applications:

    • Immunohistochemistry (IHC): Enables high-sensitivity protein detection in formalin-fixed, paraffin-embedded or frozen tissue sections.
    • Immunocytochemistry (ICC): Suitable for single-cell or monolayer cultures requiring enhanced signal.
    • In situ hybridization (ISH): Amplifies detection of nucleic acid targets for spatial transcriptomics studies.
    • Multiplexed imaging: Cy5 emission is spectrally distinct, allowing multiplexed detection with other fluorophores.
    • Detection of metabolic markers: Used in studies of lipid metabolism-related proteins, such as SCD1, CD36, and their regulation by miR-3180 (Hong et al., 2023).

    This article extends previous coverage by providing updated benchmarks and clarifying optimal storage and workflow integration, compared to the overview in GalanthamineHBr's review.

    Common Pitfalls or Misconceptions

    • Not suitable for enzyme-based chromogenic detection: The kit is strictly optimized for fluorescence, not colorimetric readouts.
    • Photobleaching: While Cy5 is photostable, prolonged exposure to high-intensity light may still cause bleaching; avoid extended imaging without anti-fade reagents.
    • Incompatibility with peroxidase-rich tissues: Endogenous peroxidases in samples can cause background; thorough quenching is essential.
    • Antibody compatibility: Only HRP-conjugated secondary antibodies can drive the amplification; alkaline phosphatase-based systems are not compatible.
    • Over-amplification risk: Excessive incubation (>10 min) may increase background signal; strict timing is required.

    Workflow Integration & Parameters

    Integration of the Cy5 TSA Fluorescence System Kit into laboratory workflows is straightforward. The kit includes dry Cy5 tyramide (to be dissolved in DMSO), 1X Amplification Diluent, and Blocking Reagent. Reconstitution and storage guidelines must be followed: Cy5 tyramide is light-sensitive and must be stored at -20°C, while other components are stable at 4°C. Typical workflow:

    1. Perform standard fixation and permeabilization procedures.
    2. Block with provided reagent to reduce non-specific binding.
    3. Incubate with primary antibody or probe specific for the target.
    4. Add HRP-conjugated secondary antibody and incubate as per protocol.
    5. Apply Cy5 tyramide working solution for 5–10 minutes at room temperature.
    6. Wash thoroughly to remove unbound substrate.
    7. Mount and image using appropriate Cy5 filter sets (excitation 648 nm, emission 667 nm).

    Parameters such as antibody dilution, incubation time, and washing steps may be optimized based on sample type and target abundance. For more on advanced multiplexing and spatial transcriptomics, see Altretamine's guide, which this article updates with new benchmarking data and storage recommendations.

    Conclusion & Outlook

    The Cy5 TSA Fluorescence System Kit (K1052) provides rapid, robust, and highly sensitive signal amplification for a range of fluorescence-based assays. Its ability to detect low-abundance targets with specificity makes it suitable for advanced research in cancer biology, neurobiology, and spatial omics. By reducing reagent consumption and streamlining workflows, the kit supports both routine and high-throughput applications. For detailed product specifications and ordering, visit the Cy5 TSA Fluorescence System Kit product page. For additional use cases and protocol variations, see the recent review on Transferrin-Fragment.com, which this article expands by including updated evidence from peer-reviewed cancer metabolism research.